# Association Between Serum Vitamin D and Albuminuria in Type 2 Diabetes Independent of Inflammatory Markers and Renal Function

**Authors:** Parisa Farshchi, Sahar Karimpour Reyhan, Mahsa Abbaszadeh, Soghra Rabizadeh, Alireza Esteghamati, Nasim Khajavi Rad, Soheil Karimpour Reyhan, Elahe Saffari, Manouchehr Nakhjavani

PMC · DOI: 10.1002/edm2.70093 · 2025-08-13

## TL;DR

Low vitamin D levels are strongly linked to kidney damage in type 2 diabetes patients, even after accounting for kidney function and inflammation.

## Contribution

Shows vitamin D deficiency correlates with albuminuria in T2D, independent of GFR and inflammatory markers.

## Key findings

- Vitamin D deficiency was 7.34 times more likely in T2D patients with albuminuria.
- High TNF-α levels were 6.77 times more common in T2D patients with albuminuria.
- Elevated hs-CRP levels were 4.7 times more frequent in T2D patients with albuminuria.

## Abstract

To explore the relationship between serum high‐sensitivity C‐reactive protein (hs‐CRP), tissue necrosis factor‐α (TNF‐α) and 25‐Hydroxyvitamin D (25(OH) vitamin D) with albuminuria in patients with type 2 diabetes mellitus (T2D).

This was a cross‐sectional study of 86 T2D patients divided into categories of with and without albuminuria based on the urine albumin‐to‐creatinine ratio (UACR). A 25(OH) vitamin D concentration ≤ 15 ng/mL was defined as vitamin D deficiency, within 15–30 ng/mL as vitamin D insufficiency, and > 30 ng/mL as serum 25(OH) vitamin D sufficiency. A hs‐CRP level ≤ 2.5 mg/L was considered low, whereas a hs‐CRP level > 2.5 mg/L was considered high. TNF‐α was classified as low or high with an 8.2 pg/mL cutoff level based on receiver operating characteristic (ROC) curve analysis. P values < 0.05 were considered to be significantly associated with albuminuria.

Vitamin D deficiency was significantly more commonly observed among T2D patients with albuminuria than those without albuminuria (adjusted OR = 7.34, 95% CI = 2.3–23.6, p = 0.001). Higher serum TNF‐α levels (TNF‐α > 8.2 pg/mL) were more frequently associated with the presence of albuminuria in T2D patients (adjusted OR = 6.77, 95% CI = 1.61–28.4; p = 0.009). Similarly, elevated serum hs‐CRP levels (hs‐CRP > 2.5 mg/L) were more commonly found among patients with T2D and albuminuria than in those without (adjusted OR = 4.7, 95% CI = 1.4–15.8; p = 0.012).

Vitamin D deficiency is a significant correlate of albuminuria in T2D patients, independent of glomerular filtration rate (GFR) and basic inflammatory markers including hs‐CRP and TNF‐α. Moreover, serum hs‐CRP > 2.5 mg/L and TNF‐α > 8.2 pg/mL were each individually associated with a significantly increased likelihood of albuminuria in T2D patients.

Vitamin D deficiency is a significant correlate of albuminuria in T2D patients, independent of eGFR and basic inflammatory markers including hs‐CRP and TNF‐α. Serum hs‐CRP > 2.5 mg/L and TNF‐α > 8.2 pg/mL were each individually associated with a significantly increased likelihood of albuminuria in T2D patients.

## Linked entities

- **Proteins:** TNF (tumor necrosis factor)
- **Diseases:** type 2 diabetes mellitus (MONDO:0005148)

## Full-text entities

- **Genes:** ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, AGT (angiotensinogen) [NCBI Gene 183] {aka ANHU, SERPINA8, hFLT1}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, REN (renin) [NCBI Gene 5972] {aka ADTKD4, HNFJ2, RTD}, IL18 (interleukin 18) [NCBI Gene 3606] {aka IGIF, IL-18, IL-1g, IL1F4}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, VDR (vitamin D receptor) [NCBI Gene 7421] {aka NR1I1, PPP1R163}
- **Diseases:** hypertension (MESH:D006973), autoimmune, or rheumatologic conditions (MESH:D001327), hyperglycemia (MESH:D006943), kidney diseases (MESH:D007674), malignancy (MESH:D009369), Diabetes (MESH:D003920), diabetic kidney disease (MESH:D003928), insulin resistance (MESH:D007333), Vitamin D deficiency (MESH:D014808), CKD (MESH:D051436), liver disease (MESH:D008107), type 1 diabetes mellitus (MESH:D003922), Albuminuria (MESH:D000419), T2D (MESH:D003924), disruption of renal function (MESH:D019958), Inflammatory (MESH:D007249), acute or chronic infections (MESH:D054198), glucose metabolism disorders (MESH:D044882)
- **Chemicals:** 25-Hydroxyvitamin D (MESH:C104450), cholesterol (MESH:D002784), lipid (MESH:D008055), creatinine (MESH:D003404), cAMP (MESH:D000242), TG (MESH:D014280), phosphate (MESH:D010710), 25 (OH) Vit D (-), Vitamin D (MESH:D014807), blood glucose (MESH:D001786), steroid hormone (MESH:D013256), Glucose (MESH:D005947), calcium (MESH:D002118)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12350185/full.md

---
Source: https://tomesphere.com/paper/PMC12350185